References
- McMahon RJ. Biotin in metabolism and molecular biology. Annu Rev Nutr. 2002;22:221–239.
- Said HM. Biotin: biochemical, physiological and clinical aspects. Subcell Biochem. 2012;56:1–19.
- Schrijver J, van Breederode N, van den Berg H, et al. Biotin in whole blood by microbiological assay; biotin in plasma or urine by RIA. In: Fidanza F, editor. Nutritional status assessment: a manual for population studies. London (UK): Chapman & Hall; 1991. p. 296–303.
- Wolf B. Heard GS. Biotinidase deficiency. In: Barness L, Oski F, editors. Advances in pediatrics. Chicago (IL): Medical Book Publishers; 1991. p. 1–21.
- Lipner SR. Rethinking biotin therapy for hair, nail, and skin disorders. J Am Acad Dermatol. 2018;78:1236–1238.
- Tourbah A, Lebrun-Frenay C, Edan G, et al., MS-SPI study group. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult Scler. 2016;22:1719–1731.
- Birnbaum G, Stulc J. High dose biotin as treatment for progressive multiple sclerosis. Mult Scler Relat Disord. 2017;18:141–143.
- Odhaib SA, Mansour AA, Haddad NS. How biotin induces misleading results in thyroid bioassays: case series. Cureus. 2019;11:e4727.
- Luong JHT, Male KB, Glennon JD. Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: an emerging threat. Biotechnol Adv. 2019;37:634–641.
- FDA. UPDATE: The FDA warns that biotin may interfere with lab tests: FDA Safety Communication. FDA; 2019. Available from: https://www.fda.gov/medical-devices/safety-communications/update-fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication
- FDA. The FDA warns that biotin may interfere with lab tests: FDA Safety Communication. FDA; 2017. Available from: https://www.fda.gov/medical-devices/safety-communications/fda-warns-biotin-may-interfere-lab-tests-fda-safety-communication
- European Commission. Commission decision 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. O J. 2002;L 221:8–36.
- Bitsch R, Salz I, Hötzel D. Biotin assessment in foods and body fluids by a protein binding assay (PBA). Int J Vitam Nutr Res. 1989;59:59–64.
- The Human Metabolome Database. Available from: http://www.hmdb.ca/metabolites/HMDB0000030
- Yagi S, Nishizawa M, Ando I, et al. A simple and rapid ultra-high-performance liquid chromatography-tandem mass spectrometry method to determine plasma biotin in hemodialysis patients. Biomed Chromatogr. 2016;30:1285–1290.
- Redeuil KM, Longet K, Bénet S, et al. Simultaneous quantification of 21 water soluble vitamin circulating forms in human plasma by liquid chromatography-mass spectrometry. J Chromatogr A. 2015;1422:89–98.
- Katzman BM, Lueke AJ, Donato LJ, et al. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem. 2018;60:11–16.
- Fujiwara M, Ando I, Yagi S, et al. Plasma levels of biotin metabolites are elevated in hemodialysis patients with cramps. Tohoku J Exp Med. 2016;239:263–267.
- IJpelaar A, Beijers A, van Daal H, et al. Prevalence of detectable biotin in The Netherlands in relation to risk on immunoassay interference. Clin Biochem. 2020;83:78–80.
- Armah S, Ferruzzi MG, Gletsu-Miller N. Feasibility of mass-spectrometry to lower cost and blood volume requirements for assessment of B vitamins in patients undergoing bariatric surgery. Metabolites. 2020;10:240.
- Li D, Ferguson A, Cervinski MA, et al. AACC guidance document on biotin interference in laboratory tests. J Appl Lab Med. 2020;5:575–587.
- Avery G. Biotin interference in immunoassay: a review for the laboratory scientist. Ann Clin Biochem. 2019;56:424–430.
- Mock DM. Biotin. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors. Modern nutrition in health and disease. 11 ed. Baltimore (MD): Lippincott Williams & Wilkins; 2014. p. 390–398.
- Wakabayashi K, Kodama H, Ogawa E, et al. Serum biotin in Japanese children: Enzyme-linked immunosorbent assay measurement. Pediatr Int. 2016;58:872–876.
- Vitamin B7. LabCorp; 2019. Available from: https://www.labcorp.com/tests/070097/vitamin-b-sub-7-sub
- Trambas CM, Liu KC, Luu H, et al. Further assessment of the prevalence of biotin supplementation and its impact on risk. Clin Biochem. 2019;65:64–65.
- Roche; 2019. Available from: https://biotinfacts.roche.com/us/en/laboratorian.html#understandingAllInterferences
- Dasgupta A, Bourgeois L. Biotin interference in TSH, FT4, and FT3 assays based on the LOCI technology: identifying interference by dilution. J Clin Lab Anal. 2019;33:e22667.